Multiparametric MRI-based nomogram integrating clinicopathological factors for predicting HER2 expression status in breast cancer - Top-Institutions - MDSpire

Multiparametric MRI-based nomogram integrating clinicopathological factors for predicting HER2 expression status in breast cancer

  • By

  • Yi Chen

  • Xiaofeng Chen

  • Bowen Yue

  • Xinwei Zhong

  • Hao Zhang

  • Xiaohong Chen

  • Xiangguang Chen

  • Zhuozhi Dai

  • Zhiqi Yang

  • June 18, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Meizhou People’s Hospital
    Meizhou People’s Hospital

    Meizhou, Guangdong

    Key Differentiators

    • Oncology

  • #2

    Harbin Medical University Cancer Hospital
    Harbin Medical University Cancer Hospital

    Harbin, Heilongjiang

    Key Differentiators

    • Oncology

  • #3

    Maastricht University Medical Centre+
    Maastricht University Medical Centre+

    Maastricht, Limburg

    Key Differentiators

    • Oncology

  • #4

    Leeds Teaching Hospitals NHS Trust
    Leeds Teaching Hospitals NHS Trust

    Leeds, West Yorkshire

    Key Differentiators

    • Oncology

  • #5

    The Christie NHS Foundation Trust
    The Christie NHS Foundation Trust

    Manchester, Greater Manchester

    Key Differentiators

    • Oncology

Original Source(s)

Multiparametric MRI-based nomogram integrating clinicopathological factors for predicting HER2 expression status in breast cancer

  • by Yi Chen, Xiaofeng Chen, Bowen Yue, Xinwei Zhong, Hao Zhang, Xiaohong Chen, Xiangguang Chen, Zhuozhi Dai, Zhiqi Yang

  • June 18, 2026

Related Content

Optical coherence tomography features and visual prognosis in vitreoretinal lymphoma: a structured phenotyping study

2026 AACR Bladder Cancer Highlights

The Lank Center for Genitourinary Oncology at Dana-Farber Cancer Institute presents a succinct summary of all the bladder cancer clinical updates you need to know from AACR 2026.

  • June 17, 2026

  • 1 min
Endocrine therapy and thyroid function in early luminal breast cancer: a controlled longitudinal retrospective analysis